ATH 20.0% 0.6¢ alterity therapeutics limited

SRPT Duchenne Drug trial hits 5 year mark, page-43

  1. 1,497 Posts.
    lightbulb Created with Sketch. 93
    Thats right Pixie, its farcical, if FDA was truly worried about safety in dogs, we would have never made it to phase 2 trials in the first place...the trial sequence has been turned upside down for us .. Animal studies became more important AFTER a batch of human trials. The FDA is a joke.

    I dont see anywhere in their approval sequence on their webpage where animal studies need to be done after phase 2 leading into phase 3
    Last edited by pierre77: 19/08/16
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
0.001(20.0%)
Mkt cap ! $31.47M
Open High Low Value Volume
0.6¢ 0.7¢ 0.6¢ $532.8K 88.39M

Buyers (Bids)

No. Vol. Price($)
7 6090323 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 30375670 37
View Market Depth
Last trade - 11.01am 17/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.